MK0524 Asthma POC Study (0524-008)(COMPLETED)

A Multicenter, Randomized, Double Blind, Crossover Study Comparing the Effect of MK0524 With Placebo and Concomitant Administration of MK0524 Plus Montelukast in Adult Patients With Chronic Asthma

The purpose of the study is to demonstrate the benefit of MK0524 compared to placebo in patients with chronic asthma.

Inclusion Criteria:

• Has symptoms of chronic asthma (shortness of breath, wheezing, chest tightness, etc.) for at least 1 year
• Nonsmoker for at least 1 year with a smoking history of no more than 7 pack-years (i.e., 1 pack per day for 7 years)

Exclusion Criteria:

• Any clinically significant disease of heart, intestinal, kidney, liver, lung or uncontrolled blood pressure
• Any surgery within 4 weeks prior to Visit 1
• Patient is intending to move or vacation for more than 5 days during the study
• Patient is pregnant or breast-feeding